| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 9 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $9.01M | - | |
| VP | 80.0K | $4.52M | - | |
| VP | 55.1K | $3.11M | - | |
| Dir | 49.4K | $2.79M | - | |
| Dir | 46.4K | $2.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2016 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 41,666 | $92.72 | $3,863,271.52 | -9.9% | |
| Jul 7, 2016 | Davis George Eric64 | EVP, General Counsel | Sell | 2,167 | $90.00 | $195,030.00 | -3.0% | |
| Jun 20, 2016 | Lawlis V Bryan53 | Director | Sell | 550 | $82.77 | $45,523.50 | -3.8% | |
| Jun 16, 2016 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 41,666 | $80.55 | $3,356,196.30 | -9.9% | |
| Jun 6, 2016 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sell | 1,649 | $89.14 | $146,991.86 | -3.4% | |
| May 31, 2016 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sale+OE | 20,841 | $89.88 | $1,873,125.75 | -16.6% | |
| May 26, 2016 | Fuchs Henry J | EVP, Chief Medical Officer | Sale+OE | 15,000 | $87.81 | $1,317,100.00 | -6.0% |